Galenica Sante Valuation
| GALE Stock | CHF 79.65 0.65 0.82% |
At this time, the firm appears to be undervalued. Galenica Sante AG retains a regular Real Value of ₣92.34 per share. The prevalent price of the firm is ₣79.65. Our model calculates the value of Galenica Sante AG from evaluating the firm fundamentals such as Current Valuation of 4.26 B, return on equity of 0.15, and Return On Asset of 0.0492 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Galenica Sante's price fluctuation is very steady at this time. Calculation of the real value of Galenica Sante AG is based on 3 months time horizon. Increasing Galenica Sante's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Galenica stock is determined by what a typical buyer is willing to pay for full or partial control of Galenica Sante AG. Since Galenica Sante is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Galenica Stock. However, Galenica Sante's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 79.65 | Real 92.34 | Hype 79.65 | Naive 78.29 |
The intrinsic value of Galenica Sante's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Galenica Sante's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Galenica Sante AG helps investors to forecast how Galenica stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Galenica Sante more accurately as focusing exclusively on Galenica Sante's fundamentals will not take into account other important factors: Galenica Sante Total Value Analysis
Galenica Sante AG is currently anticipated to have takeover price of 4.26 B with market capitalization of 3.74 B, debt of 579.88 M, and cash on hands of 164.98 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Galenica Sante fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.26 B | 3.74 B | 579.88 M | 164.98 M |
Galenica Sante Investor Information
About 50.0% of the company shares are owned by institutional investors. The book value of Galenica Sante was currently reported as 23.35. The company last dividend was issued on the 13th of May 2022. Based on the measurements of operating efficiency obtained from Galenica Sante's historical financial statements, Galenica Sante AG is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Galenica Sante Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Galenica Sante has an asset utilization ratio of 149.45 percent. This indicates that the Company is making ₣1.49 for each dollar of assets. An increasing asset utilization means that Galenica Sante AG is more efficient with each dollar of assets it utilizes for everyday operations.Galenica Sante Ownership Allocation
Galenica Sante AG has a total of 49.64 Million outstanding shares. 30% of Galenica Sante AG outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Galenica Sante Profitability Analysis
The company reported the revenue of 3.83 B. Net Income was 167.68 M with profit before overhead, payroll, taxes, and interest of 427.92 M.About Galenica Sante Valuation
Our relative valuation model uses a comparative analysis of Galenica Sante. We calculate exposure to Galenica Sante's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Galenica Sante's related companies.Galenica AG operates as a healthcare provider in Switzerland and internationally. The company was incorporated in 2017 and is headquartered in Bern, Switzerland. Galenica Sant operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 77 people.
8 Steps to conduct Galenica Sante's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Galenica Sante's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Galenica Sante's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Galenica Sante's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Galenica Sante's revenue streams: Identify Galenica Sante's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Galenica Sante's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Galenica Sante's growth potential: Evaluate Galenica Sante's management, business model, and growth potential.
- Determine Galenica Sante's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Galenica Sante's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Galenica Stock Analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.